Ipamorelin

Ipamorelin 10mg is a synthetic pentapeptide studied in research settings for its role in stimulating growth hormone secretion through selective activation of the ghrelin receptor pathway. In simple terms, researchers use Ipamorelin to better understand how targeted signaling at the pituitary level can influence natural growth hormone release without broadly affecting other endocrine hormones in …

$40.00

Ipamorelin is a synthetic pentapeptide studied in research settings for its role in stimulating growth hormone secretion through selective activation of the ghrelin receptor pathway. In simple terms, researchers use Ipamorelin to better understand how targeted signaling at the pituitary level can influence natural growth hormone release without broadly affecting other endocrine hormones in controlled laboratory models.

From a technical standpoint, Ipamorelin is a growth hormone secretagogue that functions as a selective agonist of the growth hormone secretagogue receptor type 1a (GHSR-1a), also known as the ghrelin receptor. It is composed of five amino acids (Aib-His-D-2-Nal-D-Phe-Lys-NH₂) and was designed to provide highly selective stimulation of growth hormone release with minimal activity on cortisol or prolactin pathways in research models. This receptor selectivity distinguishes it from earlier secretagogues, making it a commonly studied compound in endocrine signaling research.

In preclinical and clinical research settings, Ipamorelin is evaluated within the somatotropic axis for its effects on pulsatile growth hormone secretion, pituitary receptor activity, and downstream IGF-1 signaling pathways. It is often studied alongside GHRH analogs to observe potential synergistic effects on endocrine response patterns and hormonal regulation mechanisms.

Ipamorelin is intended strictly for laboratory research purposes only and is not approved for human consumption, medical use, or diagnostic applications.

Key Research Areas

  • Growth hormone secretagogue receptor (GHSR-1a) activation
  • Pituitary growth hormone secretion studies
  • Somatotropic axis and endocrine signaling research
  • Pulsatile hormone release modeling
  • Selective ghrelin receptor pathway studies

Chemical Information

  • Compound Name: Ipamorelin
  • Type: Synthetic pentapeptide
  • Mechanism: Selective growth hormone secretagogue (ghrelin receptor agonist)
  • Selectivity: Minimal reported activity on cortisol/prolactin pathways in research models
  • Research Focus: Endocrine and growth hormone signaling pathways

Important Notice

This compound is sold strictly for laboratory research purposes only. It is not intended for human consumption, medical treatment, or diagnostic use. Proper handling and regulatory compliance are required by the purchaser.

Additional information